What will be the predicted Move for EnteroMedics Inc. (NASDAQ:ETRM) on 7th day after earnings?


EnteroMedics Inc. (NASDAQ:ETRM) moved up 4.78% and closed its last trading session at $0.11. This Medical Sector stock currently has the Market Capitalization of 7.01 Million. The Average Volume for the stock is measured as 7.41 Million. The Stock has a 52-Week High of $4.95 and 52-Week Low of $0.09 following the dates, it touched its 52-Week High on Nov 2, 2015 and 52-Week Low on Oct 18, 2016. Currently, the Return on Assets value for the trailing twelve months is -165.3% with the Return on Equity and Return on Investment of 0% and -568.7% respectively. This firm currently has YTD (year to date) performance of -94.61 Percent which is not good. The Short Ratio for the stock is 0.59.

EnteroMedics Inc. (NASDAQ:ETRM) Price to Earnings (P/E) ratio is 0. EPS or Earning per Share stands at $-2.98. The TTM operating margin is 0 percent.

EnteroMedics Inc. (NASDAQ:ETRM) is due to report its Earnings on Mon 14 Nov (In 22 Days). The estimated EPS for the current quarter is said to be $-0.5. Following Earnings result, share price were DOWN 12 times out of last 26 Qtrs. The stock has reduced about -42.1% since it reported its last earnings. The Closing price of EnteroMedics Inc. (NASDAQ:ETRM) at Last Earnings was $0.19 as compared to the previous closing price of $0.1. The Predicted Move on the 7th day after EnteroMedics Inc. (NASDAQ:ETRM) will release its earnings at about 7%.

By Looking at Earnings History, Out of 12 Quarters when the Earnings were reported, EnteroMedics Inc. (NASDAQ:ETRM) beats earnings by 33%, The Stock Missed Earnings  4  times and has met earnings  4  times.

Earnings History:

We will discuss the past Quarters Earnings below:

EnteroMedics Inc. (NASDAQ:ETRM) reported its previous quarter on 08/04/2016 where it reported the Actual Earnings of $-0.49. The Closing price before the company posted its earnings was $0.19. The Stock surged on the very next day of earnings and maintained its stock price at $0.19 by showing a % change of 0 percent from its previous closing price. The Next Day Volume after Earnings was reported as 6.6 Million. On the 7th day After Earnings Report, the stock hit its share price as $0.17 by showing -10.53% decrease from the Stock price Before Earnings were reported.

On 05/05/2016, the stock reported the EPS of $-0.94 where Analysts were projecting the EPS to be $-0.8 showing a difference of $-0.14. Thus Surprise Factor was there with -17.5 percent. Before Earnings Announcement on 05/05/2016, the firm had its stock price of $0.75. And immediately on the next day after earnings announcement, the stock declined 0% and closed its trading session at $0.75. On 7th Day after earnings release, EnteroMedics Inc. (NASDAQ:ETRM) dropped to -10.67% from $0.75 to $0.67.

On 04/28/2016, Analysts were suspecting EPS of $-0.9/share where EnteroMedics Inc. (NASDAQ:ETRM) reported its Actual EPS of $-0.95. Thus showing a Surprise of -5.6 percent. The Closing Price of the stock before earnings was $0.93 while on the Next day the stock closed its trading session at $0.84 with a percentage change of -9.68% from the price of 0.93 before Earnings. The Stock Closing Price on the 7th day of earnings was $0.75.

Company Profile:

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The company develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It has collaboration with Mayo Clinic for the development and testing of products for the treatment of obesity. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.